arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ELUTIA INC.

ELUT
$0.87 ▼ -0.01 (-1.56%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
8 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
42
Health
Weak
Neutral
auto_awesome

Analytical Summary

ELUTIA INC. demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Operating Margin (%) which shows concerning trends. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $36.0M
Dividend Yield
Revenue Growth -15.0%
Op. Margin -218.9%
ROIC -97.3%
FCF / Share $-1.13
Trailing P/E 0.7x
Price / Book 1.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 5, 2026.

8-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$12.29M
↓ -15.0%
Net Income Profit after all expenses
$53.38M
↑ +198.9%
Operating Margin Operating profit as % of sales
-218.9%
↓ -3.1% 0th
FCF / Share Free cash flow per share
$-1.13
↓ -40.6%
Long-Term Debt Long-term obligations
$22.60M
↑ +11.0%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability
0
Returns
100
Financial Health
39
Cash Quality
11

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 29 quarters